Literature DB >> 15044589

Generation of two distinct functional isoforms of dosage-sensitive sex reversal-adrenal hypoplasia congenita-critical region on the X chromosome gene 1 (DAX-1) by alternative splicing.

Anwar Hossain1, Chun Li, Grady F Saunders.   

Abstract

DAX-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita-critical region on the X chromosome gene 1; NR0B1) is an orphan nuclear receptor that plays an important role in the development and functioning of the adrenal gland and hypothalamic-pituitary gonadal axis. The DAX-1 protein acts as a transcriptional repressor of genes involved in the steroidogenic pathway. We have identified a novel isoform encoded by the known exon 1 of DAX-1 and a previously unrecognized exon (exon 2alpha) that lies within intron 1 of DAX-1. This novel transcript, which we designated DAX-1alpha, is terminated at exon 2alpha; the last 70 amino acids of the C-terminal repressor domain encoded by exon 2 are absent. DAX-1alpha encodes a protein of 401 amino acids; the first 389 amino acids are encoded by exon 1 and the last 12 are encoded by exon 2alpha. Using conventional RT-PCR and real-time RT-PCR analyses, we found that DAX-1alpha is abundantly expressed in the adrenal gland, brain, kidney, ovary, and testis. We also found that DAX-1alpha can bind to steroidogenic factor 1 and to DNA but is unable to repress steroidogenic factor 1-mediated transcriptional activation of the reporter gene and acts as an antagonist of DAX-1 under certain conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044589     DOI: 10.1210/me.2003-0176

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  11 in total

Review 1.  Adrenocortical stem and progenitor cells: unifying model of two proposed origins.

Authors:  Michelle A Wood; Gary D Hammer
Journal:  Mol Cell Endocrinol       Date:  2010-11-20       Impact factor: 4.102

Review 2.  The orphan nuclear receptors at their 25-year reunion.

Authors:  Shannon E Mullican; Joanna R Dispirito; Mitchell A Lazar
Journal:  J Mol Endocrinol       Date:  2013-11-26       Impact factor: 5.098

3.  Evidence of adrenal failure in aging Dax1-deficient mice.

Authors:  Joshua O Scheys; Joanne H Heaton; Gary D Hammer
Journal:  Endocrinology       Date:  2011-07-05       Impact factor: 4.736

Review 4.  DAX1: Increasing complexity in the roles of this novel nuclear receptor.

Authors:  Edward R B McCabe
Journal:  Mol Cell Endocrinol       Date:  2007-01-08       Impact factor: 4.102

5.  DAX-1A (NR0B1A) expression levels are extremely low compared to DAX-1 (NR0B1) in human steroidogenic tissues.

Authors:  Y Nakamura; C Vargas Morris; H Sasano; W E Rainey
Journal:  Horm Metab Res       Date:  2008-09-25       Impact factor: 2.936

6.  Dax-1 and steroid receptor RNA activator (SRA) function as transcriptional coactivators for steroidogenic factor 1 in steroidogenesis.

Authors:  Bin Xu; Wei-Hsiung Yang; Isabelle Gerin; Chang-Deng Hu; Gary D Hammer; Ronald J Koenig
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

Review 7.  Naturally occurring C-terminal splice variants of nuclear receptors.

Authors:  Michiel van der Vaart; Marcel J M Schaaf
Journal:  Nucl Recept Signal       Date:  2009-06-19

Review 8.  In search of adrenocortical stem and progenitor cells.

Authors:  Alex C Kim; Ferdous M Barlaskar; Joanne H Heaton; Tobias Else; Victoria R Kelly; Kenneth T Krill; Joshua O Scheys; Derek P Simon; Alessia Trovato; Wei-Hsiung Yang; Gary D Hammer
Journal:  Endocr Rev       Date:  2009-04-29       Impact factor: 19.871

Review 9.  Human glucocorticoid receptor isoform beta: recent understanding of its potential implications in physiology and pathophysiology.

Authors:  Tomoshige Kino; Yan A Su; George P Chrousos
Journal:  Cell Mol Life Sci       Date:  2009-07-26       Impact factor: 9.261

10.  LXXLL motifs and AF-2 domain mediate SHP (NR0B2) homodimerization and DAX1 (NR0B1)-DAX1A heterodimerization.

Authors:  Anita K Iyer; Yao-Hua Zhang; Edward R B McCabe
Journal:  Mol Genet Metab       Date:  2007-08-07       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.